| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 公司是专业从事化学药品制剂、中成药制剂、原料药的研发、生产、销售的医药高新技术企业。公司秉承“质量第一、健全体系、持续改进、满足客户”的质量方针，不断推出符合行业发展趋势的产品，现有在册产品115款，具备片剂、硬胶囊剂、滴眼剂、凝胶剂、乳膏剂等多个剂型产品和原料药的研发、生产能力以及中药前处理及提取能力，形成以利可君片、玉屏风胶囊、醋氯芬酸肠溶片、尼群洛儿片等高新技术产品为主的多元产品系列，产品功能覆盖提升白细胞、增强免疫力、治疗关节疾病、抗高血压、抗眼部感染、治疗支气管炎、保护肝功能等多个治疗领域，并正致力于研发治疗郁郁症、肿瘤、胃病等其他疾病的药物，以满足市场及临床的需要。 | ||||||||||||||||||||||||
| Main Business | 公司是一家专业从事药物研发、生产的高新技术企业。 | ||||||||||||||||||||||||
| Legal Representative | 耿仲毅 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 翟建中 | ||||||||||||||||||||||||
| Solicitors | 北京市金杜律师事务所 | ||||||||||||||||||||||||
| Auditors | 信永中和会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0511-88898101-8081 | ||||||||||||||||||||||||
| Fax No | 0511-88889488 | ||||||||||||||||||||||||
| Website | www.jbepharm.com | ||||||||||||||||||||||||
| ir@jbepharm.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 18/05/2020 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 1.170 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 10.074 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 5.081B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |